(Disclosure: Rose Law Group Founder and President Jordan Rose is a member of the Barrow Neurological Foundation Board of Trustees.)
By InBusiness Phoenix
Barrow Neurological Institute is partnering with Plaza Companies and Holualoa Companies to develop an innovative new 10,000-square-foot dry laboratory at Park Central that will further establish Phoenix as a destination center for medical discovery.
Investigative work at the Barrow Neuro Analytics Center will span nearly all categories of neurologic diseases, including neurodegenerative diseases (Alzheimer’s, Parkinson’s, and ALS), vascular diseases (stroke and subarachnoid hemorrhage), headache and pain disorders, epilepsy, neuroinflammatory disorders (MS), and malignant brain tumors).
The new facility will be located in the Lieb Building at Park Central, between Barrow’s main campus and Creighton University Medical School. When fully occupied, this space will house eight to ten principal investigators, each with their respective support staff to create a neurological disease research center of excellence.
The laboratory will house offices and work stations as well as two large open tables for undergraduate, graduate, and medical students, and conference/common spaces to foster collaboration among the 56 full-time employees and 16 student trainees. It is partially funded by a $1 million grant from the federal government secured with the help of Senator Krysten Sinema. Barrow also recently received ARPA funding with a $10 million grant through the Governor’s Office to fund a study of COVID-19’s effect on Alzheimer’s Disease patients.
The Barrow Neuro Analytics Center will provide an ideal training and collaboration setting for students from Creighton University Medical School, Arizona State University, and the University of Arizona College of Medicine to build research capacity in Phoenix.
